Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2008

01-10-2008 | Short Research Report

Attitudes of pharmacy students toward people with mental disorders, a six country study

Authors: J. Simon Bell, S. Elina Aaltonen, Elina Bronstein, Franciska A. Desplenter, Veerle Foulon, Anna Vitola, Ruta Muceniece, Manjiri S. Gharat, Daisy Volmer, Marja S. Airaksinen, Timothy F. Chen

Published in: International Journal of Clinical Pharmacy | Issue 5/2008

Login to get access

Abstract

Objective To compare and contrast the extent to which pharmacy students in Australia, Belgium, Finland, India, Estonia and Latvia hold stigmatising attitudes toward people with schizophrenia and severe depression. Method Data were collected as part of the International Pharmacy Students Health Survey, a census survey of third-year pharmacy students studying at eight universities in six countries. Respondents (n = 642) indicated how strongly they endorsed six stigmatising statements about patients with schizophrenia and severe depression. Coded data were analysed using the Statistical Package for the Social Sciences (Version 14.0). Results Between 52.5% (95% CI 46.2–58.9%) of students in Australia and 65.1% (95% CI 56.9–73.3) in Finland agreed that people with schizophrenia are a danger to others. Between 30.3% (95% CI 24.5–36.1%) of students in Australia and 60.0% (95% CI 48.5–71.5) in Estonia and Latvia agreed that people with schizophrenia are difficult to talk to. Between 9.8% (95% CI 4.0–15.6%) of students in Belgium and 43.8% (95% CI 35.3–52.3%) in Finland agreed that people with severe depression have themselves to blame. Conclusion Sub-optimal attitudes toward people with schizophrenia and severe depression were common among pharmacy students in all countries. New models of pharmacy education are required to address the attitudes and misconceptions among pharmacy students.
Literature
2.
go back to reference Nordt C, Rössler W, Lauber C. Attitudes of mental health professionals toward people with schizophrenia and major depression. Schizophr Bull 2006;32:709–14.PubMedCrossRef Nordt C, Rössler W, Lauber C. Attitudes of mental health professionals toward people with schizophrenia and major depression. Schizophr Bull 2006;32:709–14.PubMedCrossRef
3.
go back to reference Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv 2004;55:1434–6.PubMedCrossRef Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv 2004;55:1434–6.PubMedCrossRef
4.
go back to reference Bell JS, Johns R, Chen TF. Pharmacy students’ and graduates’ attitudes towards people with schizophrenia and severe depression. Am J Pharm Educ 2006;70:77.PubMed Bell JS, Johns R, Chen TF. Pharmacy students’ and graduates’ attitudes towards people with schizophrenia and severe depression. Am J Pharm Educ 2006;70:77.PubMed
5.
go back to reference Hayward P, Bright JA. Stigma and mental illness: a review and critique. J Ment Health 1997;6:345–54.CrossRef Hayward P, Bright JA. Stigma and mental illness: a review and critique. J Ment Health 1997;6:345–54.CrossRef
6.
go back to reference Crisp AH, Gelder MG, Rix S, Meltzer HI, Rowlands OJ. Stigmatisation of people with mental illness. Br J Psychiatry 2000;177:4–7.PubMedCrossRef Crisp AH, Gelder MG, Rix S, Meltzer HI, Rowlands OJ. Stigmatisation of people with mental illness. Br J Psychiatry 2000;177:4–7.PubMedCrossRef
7.
go back to reference Mukherjee R, Fialho A, Wijetunge A, Checinski K, Surgenor T. The stigmatisation of psychiatric illness: the attitudes of medical students and doctors in a London teaching hospital. Psychiatr Bull 2002;26:178–81.CrossRef Mukherjee R, Fialho A, Wijetunge A, Checinski K, Surgenor T. The stigmatisation of psychiatric illness: the attitudes of medical students and doctors in a London teaching hospital. Psychiatr Bull 2002;26:178–81.CrossRef
8.
go back to reference Vainio KK, Airaksinen M, Hyykky TT, Enlund H. Effect of therapeutic class on counselling in community pharmacies. Ann Pharmacother 2002;36:781–6.PubMedCrossRef Vainio KK, Airaksinen M, Hyykky TT, Enlund H. Effect of therapeutic class on counselling in community pharmacies. Ann Pharmacother 2002;36:781–6.PubMedCrossRef
9.
go back to reference Bell JS, Johns R, Rose G, Chen TF. A comparative study of consumer participation in mental health pharmacy education. Ann Pharmacother 2006;40:1759–65.PubMedCrossRef Bell JS, Johns R, Rose G, Chen TF. A comparative study of consumer participation in mental health pharmacy education. Ann Pharmacother 2006;40:1759–65.PubMedCrossRef
10.
go back to reference Chung KF, Chen EYH, Liu CSM. University students’ attitudes toward mental patients and psychiatric treatment. Int J Soc Psychiatry 2001;47:63–72.PubMedCrossRef Chung KF, Chen EYH, Liu CSM. University students’ attitudes toward mental patients and psychiatric treatment. Int J Soc Psychiatry 2001;47:63–72.PubMedCrossRef
Metadata
Title
Attitudes of pharmacy students toward people with mental disorders, a six country study
Authors
J. Simon Bell
S. Elina Aaltonen
Elina Bronstein
Franciska A. Desplenter
Veerle Foulon
Anna Vitola
Ruta Muceniece
Manjiri S. Gharat
Daisy Volmer
Marja S. Airaksinen
Timothy F. Chen
Publication date
01-10-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9211-x

Other articles of this Issue 5/2008

International Journal of Clinical Pharmacy 5/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine